Ovarian Cancer Current Events | Ovarian Cancer News | 2
|
| Page
2 of
89 |
1776 Results |
|
|
|
Sort By:
Page Views | Date |
Researchers working on a better method of detecting ovarian cancer
According to the National Cancer Institute, ovarian cancer causes more deaths than any other cancer of the female reproductive system. An estimated 20,180 new cases of ovarian cancer are expected in the United States this year. view more (2006-04-04)
Scientists from University of Hawaii at Manoa find genetic marker
A new genetic marker associated with ovarian cancer risk was recently discovered by an international research group, led by scientists from the Cancer Research Genetic Epidemiology Unit in the United Kingdom. view more (2009-09-01)
Young early stage ovarian cancer patients can preserve fertility
A new study finds that young women with early-stage ovarian cancer can preserve future fertility by keeping at least one ovary or the uterus without increasing the risk of dying from the disease. view more (2009-08-10)
Swedish researchers link endometriosis with increased risk of some cancers
Madrid, Spain: Women with endometriosis have an increased risk of developing ovarian cancer, non-Hodgkin's lymphoma, endocrine and brain cancers, a Swedish researcher told the annual meeting of the European Society of Human Reproduction and Embryology today (Wednesday 2 July). However, Dr Anna-Sofia Berglund said that since these were relatively... view more... (2003-06-29)
Study suggests chemotherapy diminishes fertility in breast cancer patients
Pre-menopausal breast cancer survivors who were treated with chemotherapy following surgery were more likely to have diminished ovarian reserve - the capacity of the ovaries to provide eggs capable of being fertilized - compared to women who have never had breast cancer, according to a study led by Dana-Farber Cancer Institute investigators. view more (2008-05-30)
Ovarian cancer responds to aspirin derivative with chemo
A new study using ovarian cancer cell lines shows promise in treating the deadly disease by combining the chemotherapy drug cisplatin with an aspirin-like compound to make recurrent cancer cells less resistant to the chemotherapy. view more (2006-02-16)
EMSY: a new gene for breast/ovarian cancer
A new human breast and ovarian cancer gene has just been described by investigators in the last issue of the journal Cell. The gene, called EMSY, also characterises a subset of breast cancer with poorer survival, which makes it a potentially important diagnostic tool. view more (2003-12-10)
Minimizing obesity's impact on ovarian cancer survival
Obesity affects health in several ways, but new research shows obesity can have minimal impact on ovarian cancer survival. A study by researchers at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center found ovarian cancer survival rates are the same for obese and non-obese women if their chemotherapy doses are closely matched... view more... (2008-12-29)
Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment
Two abstracts underscoring the importance of testing for BRCA1/2 mutations in women with ovarian cancer were presented at this week's Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancers, by researchers from The University of Texas M. D. Anderson Cancer Center. view more (2008-03-11)
Prophylactic surgeries prevent two gynecological cancers in women with Lynch syndrome
Women diagnosed with Lynch syndrome, a condition often associated with colon cancer, also are at high risk for endometrial and ovarian cancers-both of which can be eliminated by having a prophylactic hysterectomy and oophorectomy (removal of the ovaries). view more (2006-01-19)
Ovarian Cancer May Mimic Fallopian Tube Formation
A new study suggests that ovarian cancer cells form by hijacking a developmental genetic process normally used to form fallopian tubes. Scientists at the Georgia Institute of Technology and the Ovarian Cancer Institute discovered that the protein, PAX8, is involved in the development of fallopian tubes and is present in ovarian cancer cells, but... view more... (2007-03-07)
HtrA1 and resistance to chemotherapy in ovarian and gastric cancers
While many cancer patients initially have a favorable response to chemotherapy for the treatment of solid tumors, resistance to treatment often develops. view more (2006-06-09)
Ovarian cancer stem cells identified, characterized
Researchers at Yale School of Medicine have identified, characterized and cloned ovarian cancer stem cells and have shown that these stem cells may be the source of ovarian cancer's recurrence and its resistance to chemotherapy. view more (2008-04-18)
Underutilized treatment for advanced ovarian cancer found to significantly improve survival
According to a study published in the January 5 issue of the New England Journal of Medicine, women with Stage III ovarian cancer given a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, experienced a median survival time 16 months longer than women who received IV chemotherapy... view more... (2006-01-05)
Computer-Assisted Detection Of Proteomic Pattern Could Help Screening For Ovarian Cancer
Issue 16 February 2002 - Early Web Publication: Friday 8 February 2002 A sensitive and non-invasive computer-assisted technique which assesses proteomic patterns in blood could be a step towards effective screening for ovarian cancer, conclude authors of a fast-track study published on The Lancet website this week.* New technologies for the... view more... (2002-02-06)
Dormant cancer cells rely on cellular self-cannibalization to survive
A single tumor-suppressing gene is a key to understanding, and perhaps killing, dormant ovarian cancer cells that persist after initial treatment only to reawaken years later, researchers at The University of Texas M. D. Anderson Cancer Center report in the December Journal of Clinical Investigation. view more (2009-01-05)
VEGF Trap shows activity in patients with advanced ovarian cancer
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. view more (2007-06-04)
The role of hormones in ovarian and endometrial cancers
High levels of the growth factor IGF-I can indicate increased risk of ovarian cancer before the age of 55. This is a finding put forward in a dissertation from Annekatrin Lukanova, Ume'å University, Sweden. The main objective of her thesis was to examine the relationship of pre-diagnostic circulating levels of sex-steroids (androgens and... view more... (2004-04-15)
Nanoparticle-delivered 'suicide' genes slowed ovarian tumor growth
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research. view more (2009-07-30)
FDA approved leukemia drugs shows promise in ovarian cancer cells
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. view more (2009-11-10)
|
|
| Page
2 of
89 |
1776 Results |
|
|
|
Sort By:
Page Views | Date |
|
